NCT01715493View on ClinicalTrials.gov

Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Chronic Obstructive Pulmonary DiseaseAsthma
Interventions
DRUG

lysozyme 90 mg

Lysozyme 90 mg three times daily for 4 weeks followed by placebo for 4 weeks (plus usual COPD medication)

DRUG

Placebo

Lysozyme Matching Placebo three times daily for 4 weeks followed by Lysozyme 90 mg three times daily for 4 weeks (plus usual COPD medication)

Trial Locations (1)

Unknown

Mizunami

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT01715493 - Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom | Biotech Hunter | Biotech Hunter